Anti-inflammatory gallic acid and wedelolactone are G protein-coupled receptor-35 agonists

Pharmacology

Volumn 89, Issue 3-4, 2012, Pages 211-219

  Deng, Huayun ^a   Fang, Ye ^a  

^a Corning Inc ^*  (United States)

Author keywords

Arrestin translocation; Caffeic acid; Cromolyn disodium; Dynamic mass redistribution; Ferulic acid; G protein coupled receptor 35; Gallic acid; Wedelolactone

Indexed keywords

BETA ARRESTIN; CAFFEIC ACID; CROMOGLYCATE DISODIUM; FERULIC ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 35; GALLIC ACID; NEDOCROMIL SODIUM; UNCLASSIFIED DRUG; WEDELOLACTONE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG EFFICACY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; CAFFEIC ACIDS; CINNAMATES; COUMARIC ACIDS; COUMARINS; CROMOLYN SODIUM; ELLAGIC ACID; GALLIC ACID; HELA CELLS; HT29 CELLS; HUMANS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84859383171     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000337184     Document Type: Article

References (23)

1. MacKenzie AE, Lappin JE, Taylor DL, Nicklin SA, Milligan G: GPR35 as a novel therapeutic target. Front Endocrin 2011; 2:e68.
2. Taniguchi Y, Tonai-Kachi H, Shinjo K: Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35. FEBS Lett 2006; 580: 5003-5008. (Pubitemid 44332369)
3. Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L: Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 2006; 281: 22021-22028. (Pubitemid 44181906)
4. Lattin JE, Schroder K, Su AI, Walker JR, Zhang J, Wiltshire T, Saijo K, Glass CK, Hume DA, Kellie S, Sweet MJ: Expression analysis of G protein-coupled receptors in mouse macrophages. Immunome Res 2008; 4: 5.
5. Sparfel L, Pinel-Marie ML, Boize M, Koscielny S, Desmots S, Pery A, Fardel O: Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene. Toxicol Sci 2010; 114: 247-259.
6. Yang Y, Lu JYL, Wu X, Summer S, Whoriskey J, Saris C, Reagan JD: G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium. Pharmacology 2010; 86: 1-5.
7. Fallarini S, Magliulo L, Paoletti T, De Lalla C, Lombardi G: Expression of functional GPR35 in human iNKT cells. Biochem Biophys Res Commun 2010; 398: 420-425.
8. Barth MC, Ahluwalia N, Anderson TJ, Hardy GJ, Sinha S, Alvarez-Cardona JA, Pruitt IE, Rhee EP, Colvin RA, Gerszten RE: Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J Biol Chem 2009; 284: 19189-19195.
9. Newman DJ, Cragg GM: Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007; 70: 461-477. (Pubitemid 46595760)
10. Kim SH, Jun CD, Suk K, Choi BJ, Lim H, Park S, Lee, SH, Shin HY, Kim DK, Shin TY: Gallic acid inhibits histamine release and proinflammatory cytokine production in mast cells. Toxicol Sci 200; 91: 123-131.
11. Lee JY, Lee JG, Sim SS, Whang WK, Kim CJ: Anti-Asthmatic effects of phenylpropanoid glycosides from Clerodendron trichotomum leaves and Rumex gmelini herbs in conscious guinea-pigs challenged with aerosolized ovalbumin. Phytomedicine 2011; 18: 134-142.
12. Yang YF, Hsu JY, Fu LS, Weng YS, Chu JJ: Asthma drugs counter-regulate interlukin-8 release stimulated by sodium sulfite in an A549 cell line. J Asthma 2008; 46: 238-243.
13. Rogerio AP, Fontanari C, Borducchi E, Keller AC, Russo M, Soares EG, Albuquerque DA, Faccioli LH: Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma. Eur J Pharmacol 2008; 580: 262-270.
14. Rogerio AP, Sa-Nunes A, Faccioli LH: The activity of medicinal plants and secondary metabolites on eosinophilic inflammation. Pharmacol Res 2010; 62: 298-307.
15. Chen S: Natural products triggering biological targets - A review of the anti-inflammatory phytochemicals targeting the arachidonic acid pathway in allergy asthma and rheumatoid arthritis. Curr Drug Targets 2011; 12: 288-301.
16. Fang Y, Ferrie AM, Fontaine NH, Mauro J, Balakrishnan J: Resonant waveguide grating biosensor for living cell sensing. Biophys J 2006; 91: 1925-1940. (Pubitemid 44352454)
17. Kenakin T: Cellular assays as portals to seven-transmembrane receptor-based drug discovery. Nat Rev Drug Discov 2009; 8: 617-626.
18. Fang Y: The development of label-free cellular assays for drug discovery. Exp Opin Drug Discov 2011; 6: 1285-1298.
19. Deng H, Hu H, Fang Y: Tyrphostin analogs are GPR35 agonists. FEBS Lett 2011; 585: 1957-1962.
20. Deng H, Hu H, He M, Hu J, Niu W, Ferrie AM, Fang Y: Discovery of 2-(4-methylfuran-2(5H)-ylidene)malononitrile and thieno[3,2-b]thiophene-2- carboxylic acid derivatives as G protein-coupled receptor-35 (GPR35) agonists. J Med Chem 2011; 54: 7385-7396.
21. Zhao P, Sharir H, Kapur A, Cowan A, Geller EB, Adler MW, Seltzman HH, Reggio PH, Heynen-Genel S, Sauer M, Chung TDY, Bai Y, Chen W, Caron MG, Barak LS, Abood ME: Targeting of the or-phan receptor GPR35 by pamoic acid: A potent activator of ERK and -Arrestin 2, with antino-ciceptive activity. Mol Pharmacol 2010; 78: 560-568.
22. Deng H, Hu H, Ling S, Ferrie AM, Fang Y: Discovery of natural phenols as G pro -tein-coupled receptor 35 (GPR35) agonists. ACS Med Chem Lett 2012; 3: 165-169.
23. Barnes PJ: Drugs for asthma. Br J Pharmacol 2006; 147:S297-S303. (Pubitemid 43077288)